Top Building Product Companies To Own In Right Now

Small cap green stocks Eco Depot Inc (OTCMKTS: ECDP), Eco Building Products Inc (OTCMKTS: ECOB) and Profire Energy, Inc (OTCBB: PFIE) has been getting some extra attention lately in various investment newsletters thanks to paid promotions or investor relation campaigns. Of course, there is nothing wrong with properly disclosed promotions and investor relations campaigns, but small cap green stocks tend to be extra volatile when compared with other stocks. So how in greenbacks will these three small cap green stocks produce for investors? Here is a quick reality check:

Eco Depot Inc (OTCMKTS: ECDP) Has the Swiss Army Knife of Water Purifiers

Small cap Eco Depot Inc was formerly an "eco lighting" distributor under new management as the company is in the development stage of transitioning into a manufacturer and distributor of eco friendly consumer brand products. On Friday, Eco Depot Inc fell 6.06% to $0.0930 for a market cap of $4.54 million plus ECDP is up 210% over the past year and down 79.8% over the past five years according to Google Finance.

Top Warren Buffett Companies To Buy For 2016: Radio One Inc.(ROIAK)

Radio One, Inc., together with its subsidiaries, operates as an urban-oriented multi-media company in the United States. It engages in the radio broadcasting operation that primarily targets African-American and urban listeners. As of December 31, 2011, the company owned and operated 54 broadcast stations located in 16 urban markets. It also operates an African-American targeted cable television network and Tom Joyner Morning Show; and owns online platform serving the African-American community through social content, news, information, and entertainment, as well as operates various online social networking Websites, including BlackPlanet, MiGente, and Asian Avenue. The company was founded in 1980 and is based in Lanham, Maryland.

Advisors' Opinion:

• [By Roberto Pedone]

  Radio One (ROIAK) is a multimedia company that primarily targets African-American and urban consumers. This stock closed up 5.8% to $2.35 in Thursday's trading session.

  Thursday's Range: $2.21-$2.40
  
  52-Week Range: $0.68-$2.66
  
  Thursday's Volume: 258,000
  
  Three-Month Average Volume: 112,595

  From a technical perspective, ROIAK ripped higher here back above its 50-day moving average of $2.27 with above-average volume. This stock recently formed a triple bottom chart pattern at $2.10, $2.11 and $2.07. Following that bottom, shares of ROIAK have started bounce sharply higher and move within range of triggering a major breakout trade. That trade will hit if ROIAK can manage to take out some near-term overhead resistance levels at $2.46 to its 52-week high at $2.66 with high volume.

  Traders should now look for long-biased trades in ROIAK as long as it's trending above some near-term support levels at $2.10 to $2.07 and then once it sustains a move or close above those breakout levels with volume that hits near or above 112,595 shares. If that breakout triggers soon, then ROIAK will set up to enter new 52-week-high territory above $2.66, which is bullish technical price action. Some possible upside targets off that breakout are $3 to $4.

• [By Roberto Pedone]

  Radio One (ROIAK), together with its subsidiaries, operates as an urban-oriented multimedia company in the U.S. This stock closed up 3% to $2.67 in Tuesday's trading session.

  Tuesday's Range: $2.56-$2.74
  
  52-Week Range: $0.68-$2.75
  
  Thursday's Volume: 99,000
  
  Three-Month Average Volume: 107,808

  From a technical perspective, ROIAK trended higher here right above some near-term support at $2.48 and above its 50-day moving average at $2.35 with decent upside volume. This move is quickly pushing shares of ROIAK within range of triggering a major breakout trade. That trade will hit if ROIAK manages to take out some near-term overhead resistance levels at $2.74 to its 52-week high at $2.75 with high volume.

  Traders should now look for long-biased trades in ROIAK as long as it's trending above support at $2.48 or above its 50-day at $2.35 and then once it sustains a move or close above those breakout levels with volume that hits near or above 107,808 shares. If that breakout triggers soon, then ROIAK will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $3.50 to $4.

Top Building Product Companies To Own In Right Now: Profire Energy Inc (PFIE)

Profire Energy, Inc., incorporated on May 5, 2003, is engaged in the business of developing combustion management technologies for the oil and gases industry. The Company manufactures, install and service oilfield combustion management technologies and related products, such as train components and secondary airplates. The Company's primary products are burner management systems. The Company�� Profire 2100 burner management system allows the end-user to manage a variety of combustion vessels. Its Profire 1300 is a flare-ignition system that provides fundamental ignition capabilities for combustor and open-flare vessels, and can relay flame-status. Its Profire 1800 is a mid-range burner management system option that provides fundamental burner management functionality, such as burner re-ignition and temperature management.

The Company also manufactures other technologies and products for sale, including specialized burner management systems intended for use in specific firetube vessels (e.g. incinerators), valve train products, including valves, gauges, and installation products, and miscellaneous componentry, such as solar-power generation kits, add-on cards to expand the functionality of a given system, and a airplate that meters secondary airflow to the burner, allowing for more optimized combustion and reduced emissions.

The Company competes with SureFire, Platinum, ACL and TitanLogix.

Advisors' Opinion:

• [By Peter Graham]

  Small cap green stocks Eco Depot Inc (OTCMKTS: ECDP), Eco Building Products Inc (OTCMKTS: ECOB) and Profire Energy, Inc (OTCBB: PFIE) has been getting some extra attention lately in various investment newsletters thanks to paid promotions or investor relation campaigns. Of course, there is nothing wrong with properly disclosed promotions and investor relations campaigns, but small cap green stocks tend to be extra volatile when compared with other stocks. So how in greenbacks will these three small cap green stocks produce for investors? Here is a quick reality check:

Top Building Product Companies To Own In Right Now: Universal Technical Institute Inc(UTI)

Universal Technical Institute, Inc. engages in the provision of postsecondary education for students seeking careers as professional automotive, diesel, collision repair, motorcycle, and marine technicians in the United States. It offers undergraduate degree, diploma, and certificate programs through its campuses under various brands, including Universal Technical Institute, Motorcycle Mechanics Institute and Marine Mechanics Institute, and NASCAR Technical Institute. The company also provides manufacturer-specific training programs comprising student paid electives at its campuses and manufacturer or dealer sponsored training at certain campuses and dedicated training centers. Universal Technical Institute, Inc. was founded in 1965 and is headquartered in Scottsdale, Arizona.

Advisors' Opinion:

• [By Eric Volkman]

  Universal Technical Institute (NYSE: UTI  ) doesn't seem like it needs to learn how to make dividend payments. The company is staying true to recent form by declaring a quarterly distribution, which is to be $0.10 per share. This will be paid on June 28 to shareholders of record as of June 21. That amount matches each of the firm's previous regular distributions, the most recent of which was disbursed in late March.

• [By Laura Brodbeck]

  Tuesday

  Earnings Expected From: Bank of Montreal (NYSE: BMO), United Natural Foods, Inc. (NASDAQ: UNFI), OmniVision Technology, Inc. (NASDAQ: OVTI), Universal Technical Institute, Inc. (NYSE: UTI) Economic Releases Expected: Chinese HSBC Services PMI, Australian GDP, Brazilian GDP, eurozone PPI, British construction PMI.

  Wednesday

• [By Seth Jayson]

  Calling all cash flows
  When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Universal Technical Institute (NYSE: UTI  ) , whose recent revenue and earnings are plotted below.

Top Building Product Companies To Own In Right Now: Idera Pharmaceuticals Inc.(IDRA)

Idera Pharmaceuticals, Inc., a biotechnology company, discovers and develops DNA- and RNA-based drug candidates for the treatment of infectious diseases, autoimmune and inflammatory diseases, cancer, and asthma and allergies, and for use as vaccine adjuvants. The company designs and creates proprietary Toll-Like Receptors (TLR) to modulate immune responses, including TLR agonist, a compound that stimulates an immune response through the targeted TLR; and TLR antagonist, a compound that blocks activation of an immune response through the targeted TLR. Its drug candidates include IMO-2125, a TLR9 agonist, which is in Phase 1 clinical trial for hepatitis C virus infection; and TLR7, 8, and 9 agonists that are in research stage for viral diseases. The company also develops IMO-3100, a dual TLR7/TLR9 antagonist, which is in preclinical development stage for autoimmune and inflammatory diseases, such as lupus, rheumatoid arthritis, multiple sclerosis, psoriasis, and colitis. In addition, its drug candidates also comprise TLR7 and TLR8 agonists that are in research stage for solid tumor cancers. The company has a licensing and collaboration agreement with Merck KGaA to research, develop, and commercialize TLR9 agonists for the treatment of cancer, excluding cancer vaccines; a license and research collaboration agreement with Merck & Co., Inc. to research, develop, and commercialize therapeutic and prophylactic vaccine products containing its TLR7, 8, and 9 agonists in the fields of cancer, infectious diseases, and Alzheimer?s disease; and a research collaboration and option agreement, and a license, development, and commercialization agreement with Novartis International Pharmaceutical, Ltd. to discover, develop, and commercialize TLR9 agonists for the treatment of asthma and allergies. The company was founded in 1989 and is based in Cambridge, Massachusetts.

Advisors' Opinion:

• [By Monica Gerson]

  Idera Pharmaceuticals (NASDAQ: IDRA) is estimated to report a Q1 loss at $0.08 per share on revenue of $3.00 thousand.

  USA Technologies (NASDAQ: USAT) is projected to report its Q3 earnings at $0.00 per share on revenue of $10.63 million.

• [By John Kell and Lauren Pollock var popups = dojo.query(".socialByline .popC"); ]

  Idera Pharmaceuticals Inc.(IDRA) said a recent clinical study of its plaque psoriasis treatment met its objectives, allowing the company to push forward with the treatment’s development. The company’s shares jumped 32% to $5.14 premarket.

• [By John Udovich]
  Follow-on Stock Offerings From Small Cap Biotech Stocks. Thanks to the boom in biotech IPOs along with the sector�� overall performance, already listed biotechs have the option to ask investors for more cash in the form of a follow-on offering. Recently, FierceBiotech.com noted how four small cap biotechs raised $276 million from follow-on offerings in just one day last week. These small caps�included Epizyme Inc (NASDAQ: EPZM) which raised $88 million, Halozyme Therapeutics, Inc (NASDAQ: HALO) which raised $100 million, Agenus Inc (NASDAQ: AGEN) which raised $52 million and Idera Pharmaceuticals Inc (NASDAQ: IDRA) which raised $36 million. FierceBiotech.com noted that the�steady flow of about $4.5 billion a year in venture cash�along with�more than $3.5 billion from IPOs last year plus all of the�follow-ons are helping to foster both company growth and�accelerate drug�development programs. Mixed Bag for Biotech IPOs. Last Wednesday also saw two small cap biotech IPOs fizzle in one day�with small cap T cell vaccine developer�Genocea Biosciences Inc (NASDAQ: GNCA) raising $60 million but then ending the day down 8.3% to close at $11 while Dutch drug developer uniQure NV (QURE) raised $81.9 million but fell more than 14% to $14.61. However, orphan drug stock Auspex Pharmaceuticals Inc (NASDAQ: ASPX), which is developing�drugs to treat orphan diseases like Tourette syndrome, saw a 30.5% gain to close at $15.66 and raise $84 million. The Boston Globe quoted Michael Ringel, a partner and managing director at Boston Consulting Group who focuses on health care business, as saying:

  ��he mood is incredibly positive. Capital is flowing. [The biotech IPOs]��have been burning hot. I think it�� too early to suggest that is changing. I can�� predict the overall economy any better than anyone else, but I would expect a pretty good year for IPOs.��/p>

• [By Dan Caplinger]

  Lately, the stock market has turned on every word from the Federal Reserve, and so this morning's comments from Federal Reserve Chairwoman Janet Yellen received a huge amount of attention from investors Monday. With Yellen offering a much more encouraging assessment of how long interest rates might remain low in order to stimulate and sustain economic growth, stocks climbed sharply, with the Dow posting triple-digit gains. Yet for MannKind (NASDAQ: MNKD  ) , Momenta Pharmaceuticals (NASDAQ: MNTA  ) , and Idera Pharmaceuticals (NASDAQ: IDRA  ) , the news today was far from good, as all three stocks suffered declines of 10% or more.

Top Building Product Companies To Own In Right Now: WesBanco Inc.(WSBC)

WesBanco, Inc. operates as a holding company for WesBanco Bank, Inc. that provides various financial products and services. It engages in generating deposits and originating loans. The company?s deposit products include interest bearing demand deposits, money market accounts, savings deposits, and certificate of deposits. Its loan portfolio comprises commercial real estate loans; commercial and industrial loans; residential real estate loans that consist of loans to purchase, construct, or refinance personal residences, including one-to-four family rental properties; home equity lines of credit; and consumer loans comprising of installment loans to finance purchases of automobiles, motorcycles, boats, and other recreational vehicles, and lines of credit. The company, through its other subsidiaries, also offers property, casualty, and life insurance, as well as benefit plan sales and administration for personal and commercial clients; and discount brokerage and asset manag ement services. In addition, it provides trust services and various investment products, including mutual funds, as well as engages in leasing commercial real estate properties. As of February 26, 2010, the company operated 114 branch locations and 138 automated teller machines in West Virginia, Ohio, and Pennsylvania. The company was founded in 1968 and is headquartered in Wheeling, West Virginia.

Advisors' Opinion:

• [By GURUFOCUS]

  WesBanco Inc. (WSBC) operates as a holding company for WesBanco Bank Inc. that provides retail banking, corporate banking, personal and corporate trust services, and mortgage banking and insurance services. Aug. 22, the company increased its quarterly dividend 5.3% to $0.20 per share. The dividend is payable Oct. 1, 2013 to shareholders of record on Sept. 13, 2013. The yield based on the new payout is 2.6%.

Top Building Product Companies To Own In Right Now: iShares International Select Dividend ETF (IDV)

iShares Dow Jones EPAC Select Dividend Index Fund (the Fund) is an exchange-traded fund that seeks investment results that correspond generally to the price and yield performance of the Dow Jones EPAC Select Dividend Index (the Index). The Index measures the performance of a selected group of equity securities issued by companies that have provided relatively high dividend yields on a consistent basis over time. The Index consists of 100 of the highest dividend-yielding securities (excluding real estate investment trusts (REITs)) in the Dow Jones World Developed-Ex. U.S. Index, an index representative of the Europe, Pacific, Asia and Canada (EPAC) regions, which covers developed markets, excluding the United States. To be included in the Index, the securities must have paid dividends in each of the previous three years; must have a previous year�� dividend per share, which is greater than or equal to its three year average dividend payout ratio; must have a five-year average dividend per share, which is less than or equal to 1.5 times the five-year average dividend payout ratio of the corresponding Dow Jones country index, and must have a minimum three-month average daily trading volume of $3,000,000 a day. The Index is reviewed annually.

The Fund invests in securities of companies that are located in or whose securities are principally traded in the markets of the EPAC regions. The Fund generally will invest at least 90% of its assets in component securities and in depositary receipts representing such securities. The Fund may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents, including money market mutual funds. The Fund will only concentrate its investments in a particular industry or group of industries to approximately the same extent that its Index is so concentrated. The Fund�� investment advisor is Barclays Global Fund Advisors. The Fund�� index provider is Dow Jones & Company, Inc. The index provider determines the rel! ative weightings of the securities in the Index and publishes information regarding the market value of the Index.

Advisors' Opinion:

• [By Selena Maranjian]

  Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some international dividend-paying stocks to your portfolio but don't have the time or expertise to hand-pick a few, the iShares Dow Jones International Select Div ETF (NYSEMKT: IDV  ) could save you a lot of trouble. Instead of trying to figure out which companies will perform best, you can use this ETF to invest in lots of them simultaneously.
  
  The basics
  ETFs often sport lower expense ratios than their mutual fund cousins. The iShares ETF's expense ratio -- its annual fee -- is a relatively low 0.50% -- and it recently yielded more than 5%!
  
  This ETF has performed �well, outstripping the MSCI EAFE index over the past three and five years. As with most investments, of course, we can't expect outstanding performances in every quarter or year. Investors with conviction need to wait for their holdings to deliver.

• [By Jim Powell]

  At the minimum, your family trust should hold the iShares Dow Jones Select Dividend Index (DVY). I also think you should consider the iShares International Select Dividend Fund (IDV) that invests in foreign companies with good payment histories.